Evidence map›Paper›PMID 40298935›Full record

ArticleThe Journal of experimental medicine2025

RORγt eTACs mediate oral tolerance and Treg induction.

Im-Hong Sun, Anita E Qualls, Han S Yin, Jiaxi Wang, Matthew P Arvedson, Joe Germino, Nolan K Horner, Sheng Zhong, Juan Du, Martin Valdearcos and 4 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. RORγtScience immunology · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Im-Hong Sun *Department of Surgery, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0003-0288-2062
Anita E Qualls *Diabetes Center, University of California, San Francisco , San Francisco, CA, USA.ORCID 0000-0003-0576-8863
Han S Yin *Diabetes Center, University of California, San Francisco , San Francisco, CA, USA.ORCID 0009-0007-5721-3022
Jiaxi Wang *Diabetes Center, University of California, San Francisco , San Francisco, CA, USA.ORCID 0000-0001-6043-9953
Matthew P ArvedsonDiabetes Center, University of California, San Francisco , San Francisco, CA, USA.ORCID 0000-0001-7717-0188
Joe GerminoDiabetes Center, University of California, San Francisco , San Francisco, CA, USA.ORCID 0000-0003-3939-3342
Nolan K HornerDepartment of Surgery, University of California, San Francisco, San Francisco, CA, USA.ORCID 0009-0004-9388-5676
Sheng ZhongDepartment of Surgery, University of California, San Francisco, San Francisco, CA, USA.ORCID 0009-0000-6178-4505
Juan DuDepartment of Surgery, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0001-7428-0576
Martin ValdearcosDiabetes Center, University of California, San Francisco , San Francisco, CA, USA.ORCID 0000-0002-5784-2458
Vasilis NtranosDiabetes Center, University of California, San Francisco , San Francisco, CA, USA.ORCID 0000-0002-2477-0670
Richard M LocksleyDepartment of Medicine, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-5468-6867
Roberto R Ricardo-GonzalezDepartment of Dermatology, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-6135-4035
James M GardnerDepartment of Surgery, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0003-3470-9520

Funding

MOLECULAR AND CELLULAR IMMUNOLOGYT32AI007334 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CYSTER, JASON G · 1988 to 2023
$11.0M
Medical Scientist Training Program (T32 NRSA Training Grant)T32GM141323 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Aimee Kao · 2021 to 2026
$10.5M
Restorative practice in repairing harm and promoting safe and inclusive practices in the laboratory.T32GM136547 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Adrian Erlebacher, Anita Sil · 2020 to 2026
$4.5M
Autoimmune Regulator gene (Aire)-mediated tolerance to pregnancy-associated self-antigensR01AI145858 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MACKENZIE, TIPPI · 2019 to 2023
$3.9M
The microbiota-microglia axis in the regulation of metabolic homeostasisR01DK134782 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Martin Valdearcos · 2023 to 2026
$1.6M
Elucidating the role of type 2 immunity in skin homeostasisK08AR075880 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RICARDO-GONZALEZ, ROBERTO RAFAEL · 2019 to 2023
$888k
Illumina NovaSeq 6000 Sequencing SystemS10OD028511 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHOW, ERIC D · 2020 to 2020
$583k
Elucidating the Role of AIRE and Tumor Associated Aire-expressing Cells in Tumor Growth and Immune EvasionF31CA288017 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Matthew Arvedson · 2024 to 2026
$126k
Defining the Role of Aire in eTACs and its Contribution to Peripheral Immune ToleranceF31AI172348 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WANG, JIAXI · 2022 to 2024
$120k
Achievement Rewards for College Scientists FoundationBurroughs Wellcome FundNCI NIH HHS F31 CA288017NIAID NIH HHS F31 AI172348NIAID NIH HHS R01 AI145858NIAID NIH HHS T32 AI007334NIAMS NIH HHS K08 AR075880NIDDK NIH HHS R01 DK134782NIGMS NIH HHS T32 GM136547NIGMS NIH HHS T32 GM141323NIH HHS 1S10OD028511-01NIH HHS S10 OD028511Parker Institute for Cancer ImmunotherapyW.M. Keck Foundation
6 · The paper itself

Abstract

The immune system must distinguish pathogens from innocuous dietary antigens, but the precise mechanisms and cellular actors remain unclear. Here, we demonstrate that RORγt-lineage APCs are required for oral tolerance. Using lineage tracing and single-cell sequencing, we show these APCs consist of three principal populations: type 3 innate lymphoid cells (ILC3s), RORγt-lineage dendritic cells, and cells expressing Aire called RORγt eTACs (R-eTACs)-also known as Janus or Thetis cells. We show that R-eTACs, but not ILC3s, are required for oral tolerance induction. We find R-eTACs are of probable myeloid origin and uniquely express integrin β8 (Itgb8). Both MHCII and Itgb8 expression in RORγt-lineage cells are necessary to induce food-specific regulatory T cells. Mice lacking R-eTACs or with deletion of MHCII or Itgb8 in the RORγt lineage fail to generate Tregs and instead develop a T-follicular helper response with elevated antigen-specific antibodies. These findings establish R-eTACs as critical mediators of oral tolerance and suggest novel cellular targets to modulate immune tolerance.

Indexed as

Immune ToleranceNuclear Receptor Subfamily 1, Group F, Member 3T-Lymphocytes, RegulatoryAIRE ProteinAnimalsCell LineageDendritic CellsImmunity, InnateIntegrin beta ChainsMiceMice, Inbred C57BLMice, KnockoutTranscription FactorsAIRE ProteinIntegrin beta ChainsNuclear Receptor Subfamily 1, Group F, Member 3Transcription Factors

Identifiers

PMID40298935
PMCPMC12039581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.